Specific antibody response after influenza immunization in systemic lupus erythematosus

Journal of Rheumatology

Volumn 29, Issue 12, 2002, Pages 2555-2557

  Abu Shakra, Mahmoud ^a,b,d   Press, Joseph ^a,b   Varsano, Noemi ^a,b,c   Levy, Virginia ^a,b   Mendelson, Ella ^a,b   Sukenik, Shaul ^a,b   Buskila, Dan ^a,b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b MINISTRY OF HEALTH   (Israel)

^c Respiratory Virus Unit   (Israel)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Influenza vaccines vaccination; Systemic lupus erythematosus; Systemic lupus erythematosus disease activity index

Indexed keywords

ANTIMALARIAL AGENT; AZATHIOPRINE; HYDROXYCHLOROQUINE; INFLUENZA VACCINE; METHOTREXATE; PREDNISONE; STEROID; INACTIVATED VACCINE; VIRUS ANTIBODY; VIRUS HEMAGGLUTININ;

ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; INFLUENZA; INFLUENZA VACCINATION; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME; VACCINATION; VIRUS INFECTION; BIOSYNTHESIS; HEMAGGLUTINATION INHIBITION TEST; HOSPITALIZATION; IMMUNOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; AGED; ANTIBODIES, VIRAL; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININS, VIRAL; HUMANS; INFLUENZA VACCINES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; VACCINATION; VACCINES, INACTIVATED;

EID: 0036897434     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Abu-Shakra M, Zalmanson S, Neumann L, Flusser D, Sukenik S, Buskila D. Influenza virus vaccination of patients with SLE: Effects on disease activity. J Rheumatol 2000;27:1681-5.
2. Abu-Shakra M, Press J, Sukenik S, Buskila D. Influenza virus vaccination of patients with SLE: Effects on generation of autoantibodies. Clin Rheumatol (In press).
3. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
4. Palmer DF, Coleman MT, Dowdle WR, Schild DC. Advanced Laboratory Techniques for Influenza Diagnosis. Public Health Service, US Department of Health, Education and Welfare. Atlanta, GA: Centers for Disease Control; 1975.
5. Gross PA, Hermogenes AW, Sacks HS. The efficacy of influenza vaccine in elderly persons: A meta-analysis and review of the literature. Ann Intern Med 1995;123:518-27.
6. Murphy BR, Clements ML. The systemic and mucosal immune response of humans to influenza A virus. Curr Top Microbiol Immunol 1989;146:107-16.
7. World Health Organization. Recommendation for the composition of influenza virus vaccines for use in 1999. Wkly Epidemiol Rec 1998;73:305-8.
8. Powes DC. Effect of age on serum immunoglobulin G subclass antibody responses to inactivated influenza virus. J Med Virol 1994;43:57-61.
9. Louie JS, Nies KM, Shoji KT, et al. Clinical and antibody responses after influenza immunization in SLE. Ann Intern Med 1978;88:790-2.
10. Williams GW, Steinberg AD, Reinertsen L, Klassen LW, Decker JL, Dolin R. Influenza immunization in SLE. A double blind trial. Ann Intern Med 1978;88:729-34.
11. Brodman R, Gilfillan R, Glass D, Schur P. Influenza vaccine response in SLE. Ann Intern Med 1978;88:735-40.
12. Ristow SC. Douglas RG, Condemi JJ. Influenza vaccination of patients with SLE. Ann Intern Med 1978;88:786-9.
13. Hess EV, Hahn HB. Influenza immunization in lupus erythematosus: Safe, effective? Ann Intern Med 1978;88:833-4.